Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
107 USD | -0.52% | -0.04% | -2.77% |
04:21pm | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
04-26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.77% | 187B | |
-1.75% | 106B | |
-4.47% | 66.9B | |
+0.58% | 49.45B | |
+16.54% | 48B | |
+4.06% | 40.84B | |
+3.61% | 26.48B | |
+1.14% | 26.25B | |
+12.96% | 24.62B | |
-0.39% | 24.52B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Sector Update: Health Care Stocks Down in Wednesday's Premarket Trading